Printer Friendly

Browse Reverse transcriptase inhibitors topic


1-75 out of 75 article(s)
Title Author Type Date Words
TDF preferred in PrEP for Blacks and women in studies. Osterweil, Neil Nov 1, 2020 1048
TDF preferred in PrEP for Blacks and women. Osterweil, Neil Nov 1, 2020 1173
Real-World Experience with Dolutegravir-Based Two-Drug Regimens. Ward, Douglas; Ramgopal, Moti; Riedel, David J.; Garris, Cindy; Dhir, Shelly; Waller, John; Roberts, Jul 31, 2020 5796
One-Pot Synthesized Nickel-Cobalt Sulfide-Decorated Graphene Quantum Dot Composite for Simultaneous Electrochemical Determination of Antiretroviral Drugs: Lamivudine and Tenofovir Disoproxil Fumarate. Chihava, Ruvimbo; Apath, Daniel; Moyo, Mambo; Shumba, Munyaradzi; Chitsa, Vitalis; Tshuma, Piwai Jul 31, 2020 7774
Colorimetric Sensor Based on [beta]-Cyclodextrin-Functionalized Silver Nanoparticles for Zidovudine Sensitive Determination. Gerayeli, Farhad Ghanizadeh; Hosseini, Farnaz; Bagheri, Zohreh; Savardashtaki, Amir; Shabaninejad, Z Jun 30, 2020 3298
HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016. Chen, Jiayi; Liu, Yang; Liu, Sijing; Yuan, Dan; Su, Ling; Ye, Li; Gong, Fanghong; Gao, Yushuang; Bal Apr 30, 2020 5768
Optimal Controls of the Highly Active Antiretroviral Therapy. Grigorieva, Ellina V.; Khailov, Evgenii N.; Korobeinikov, Andrei Mar 1, 2020 16247
PFA to check ice factories, beverage makers. Apr 1, 2019 199
Primary HIV Drug Resistance among Recently Infected Cases of HIV in North-West India. Chauhan, C.K.; Lakshmi, P.V.M.; Sagar, V.; Sharma, A.; Arora, S.K.; Kumar, R. Mar 31, 2019 4538
Influence of Phosphatidylinositol-3-Kinase/Protein Kinase B-Mammalian Target of Rapamycin Signaling Pathway on the Neuropathic Pain Complicated by Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV Infection. Report Aug 5, 2018 5968
A proposed management algorithm for late-onset efavirenz neurotoxicity. Cross, H.M.; Chetty, S.; Asukile, M.T.; Hussey, H.S.; Pan, E.B.Lee; Tucker, L.M. Report Apr 1, 2018 3132
A nonlinear QSAR Study Using Oscillating Search and SVM as an Efficient Algorithm to Model the Inhibition of Reverse Transcriptase by HEPT Derivatives. Report Feb 28, 2018 5757
Acute Liver Failure among Patients on Efavirenz-Based Antiretroviral Therapy. Segamwenge, Innocent Lule; Bernard, Miriam Kaunanele Jan 1, 2018 3072
Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults. Badii, Vitus Sambo; Buabeng, Kwame Ohene; Poku, Thomas Agyarko; Forkuo, Arnold Donkor; Boamah, Brigh Jan 1, 2018 6152
Matrix IT Medical, SAIT s.r.l. & Videx Win AIM 2017 Case Study Competition. Sep 21, 2017 578
Zidovudina/Lamivudina vs Abacavir/Lamivudina vs Tenofovir/Emtricitabina en combinaciones de dosis fija como tratamiento inicial en pacientes con VIH: revision sistematica y metanalisis en red. Alzate Angel, Juan Carlos; Duque Molina, Marcela Maria; Garcia Garcia, Hector Ivan Ensayo Apr 1, 2017 9591
Unusual Case of Lamivudine-Associated Skin Rashes in an HIV/AIDS Patient: A Case Presentation. Khan, Kashif U.; Khan, Amer H.; Sulaiman, Syed A.; Soo, Chow T.; Ahmad, Syed I. Apr 1, 2017 1182
A Single Zidovudine (AZT) Administration Delays Hepatic Cell Proliferation by Altering Oxidative State in the Regenerating Rat Liver. Butanda-Ochoa, Armando; Hernandez-Espinosa, Diego Rolando; Olguin-Martinez, Marisela; Sanchez-Sevill Jan 1, 2017 8019
Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability. Gupta, Shweta; Kesarla, Rajesh; Chotai, Narendra; Misra, Ambikanandan; Omri, Abdelwahab Author abstract Jan 1, 2017 10659
Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection. Vial, Romain; Zandotti, Christine; Alain, Sophie; Decourt, Alexandre; Jourde-Chiche, Noemie; Purgus, Case study Jan 1, 2017 3759
Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review. Balayan, Tatevik; Horvath, Hacsi; Rutherford, George W. Report Jan 1, 2017 5182
Efficacy and Tolerability of Tenofovir Disoproxil Fumarate Based Regimen as Compared to Zidovudine Based Regimens: A Systematic Review and Meta-Analysis. Dadi, Tegene Legese; Kefale, Adane Teshome; Mega, Teshale Ayele; Kedir, Muktar Sano; Addo, Habtamu A Report Jan 1, 2017 3891
Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel. Munkwase, Grant; Bisaso, Kuteesa R.; Kakaire, Othman; Nanzigu, Sarah Jan 1, 2017 3782
Mylan unveils generic Viramune XR Extended-Release HIV-1Tablets, 100 mg. Nov 17, 2015 148
Mylan unveils generic Viramune XR Extended-Release HIV-1Tablets, 100 mg. Nov 17, 2015 144
Efavirenz: a review of the epidemiology, severity and management of neuropsychiatric side-effects. Gaida, R.; Truter, I.; Grobler, C. Report Aug 1, 2015 3428
Mylan unveils generic Viramune XR in the US for antiretroviral treatment. Oct 31, 2014 125
Mylan unveils generic Viramune XR in the US for antiretroviral treatment. Oct 31, 2014 121
Mylan unveils generic Combivir in the US, strengthening its growing antiretroviral franchise in the nation. Oct 7, 2014 152
Mylan unveils generic Combivir in the US, strengthening its growing antiretroviral franchise in the nation. Oct 7, 2014 148
AZT associated with poorer immunological recovery in people taking first-line HIV treatment in southern Africa. Carter, Michael Jun 1, 2013 920
Gilead Sciences Inc gets European Commission's approval for marketing once-daily Viread. Nov 28, 2012 208
Gilead Sciences Inc gets European Commission's approval for marketing once-daily Viread. Nov 28, 2012 194
Mylan Inc unveils generic Epivir Tablets in the UK and Italy, its first generic ARV launch in Europe. Jun 7, 2012 144
Clinigen wins US FDA approval for Foscavir in HIV/AIDS-related cytomegalovirus infections and herpes. May 8, 2012 212
Safety, strength and simplicity of efavirenz in pregnancy. Pillay, Prinitha; Black, Vivian Report Mar 1, 2012 6047
Mylan Inc awarded tentative FDA approval for Abacavir Sulfate and Lamivudine Tablets for pediatric HIV/AIDS. Feb 24, 2012 167
Gilead Sciences Inc awarded US FDA approval for three new lower-strength tablets of Viread for HIV infected children. Jan 19, 2012 208
FDA okays oral powder formulation of Viread. Jan 19, 2012 117
Lemming-food plant interactions, density effects, and cyclic dynamics on the siberian tundra. Erlinge, Sam; Hasselquist, Dennis; Hogstedt, Goran; Seldal, Tarald; Frodin, Peter; Svensson, Mikael Report Dec 1, 2011 5536
Gilead unveils new 5-year trial data on Viread's efficacy in HBV patients. Clinical report Nov 7, 2011 435
CHMP adopts positive opinion on generic version of Sustiva. Oct 25, 2011 146
Antiretroviral adverse drug reactions and their management: how to recognise, manage and avoid adverse effects of antiretrovirals. Orrell, Catherine Jun 1, 2011 3250
Mylan Inc awarded FDA approval for Zidovudine Tablets, 100 mg to control HIV infection. Mar 11, 2011 164
FDA study finds no link between Ziagen and heart attacks. Mar 1, 2011 1540
How HIV resists AIDS preventing AZT drug. Sep 20, 2010 294
A new AIDS drug from GlaxoSmithKline Plc (Brentford UK) and its partner Shionogi & Co Ltd (Osaka, Japan) works faster and has fewer side effects than Bristol-Myers Squibb's (New York) older medicine Sustiva, researchers said. Jul 26, 2010 772
A dimeric high-molecular-weight chymotrypsin inhibitor with antitumor and HIV-1 reverse transcriptase inhibitory activities from seeds of Acacia confusa. Lam, S.K.; Ng, T.B. Report Jul 1, 2010 3781
Viral load response and side effect differences with recommended antiretrovirals. Apr 1, 2010 1567
Gilead and Tibotec team up. Brief article Aug 3, 2009 207
French study sees heart attack risk with recent Ziagen. Mar 1, 2009 1369
Does Ziagen raise heart disease risk? Dec 1, 2008 1794
One in five people stopping a nonnucleoside may get. Dec 1, 2008 1307
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients. Kaul, Rupert Clinical report Dec 1, 2008 383
Efavirenz may have edge for advanced HIV. London, Susan Oct 1, 2008 620
New protease inhibitors and non-nucleoside reverse transcriptase inhibitors. Lascar, Monica; Cartledge, Jonathan D. Drug overview Jun 1, 2008 3759
Nucleoside analogues in 2008. Warwick, Zoe; Churchill, Duncan Mar 1, 2008 6113
Key clinical trials of non-nucleoside reverse transcriptase inhibitors in the treatment of chronic HIV-1 infection in adults. Williams, Ian G. Report Mar 1, 2008 3971
Football: PFA claim game in crisis over foreigners. Dec 8, 2007 670
Football: Heroes like JT are an inspiration ...they are worth every last penny; Pay fury: PFA chief Gordon Taylor hits back after footballers' salaries slated. Nov 2, 2007 644
Outcomes of children on non-nucleoside reverse transcriptase inhibitor versus protease inhibitor HAART regimens in resource-limited settings. Jaspan, Heather B.; Boulle, Andrew; Berrisford, Alison; Roux, Paul Clinical report Jun 1, 2007 654
Non-nucleoside reverse transcriptase inhibitor (NNRTI) HIV treatment regimens are better at suppressing the virus than protease inhibitor (PI) regimens. Brief article Jan 1, 2007 148
New NNRTIs target resistant HIV. Finn, Robert Drug overview Mar 15, 2006 361
Starting antiretrovirals for chronic HIV in adults. Mechcatie, Elizabeth; Boschert, Sherry Dec 1, 2005 1313
Nevirapine can lead to hepatotoxicity in women: medwatch alert. Perlstein, Steve Mar 15, 2004 327
Nevirapine can lead to hepatotoxicity in women. Perlstein, Steve Mar 15, 2004 334
Watch for 'bumper crop' of HIV drugs. Finn, Robert Mar 15, 2004 707
Viramune boxed warning. Brief Article Mar 1, 2004 157
Nevirapine precautions published. Brief Article Feb 27, 2004 184
Revised guidelines simplify HIV/AIDS regimens; 'preferred' and 'alternative' regimens. Finn, Robert Feb 1, 2004 566
Bristol-Myers, Gilead win approvals for HIV/AIDS treatments. (Rx/Branded Drugs). Brief Article Jul 21, 2003 254
Tenofovir good add-on drug for resistant HIV infections. (New Anti-HIV Therapy). Brief Article Mar 1, 2002 479
Seen and heard. (Bottom Lines). Brief Article Jul 1, 2001 273
Efavirenz interference in estradiol ELISA assay. Sinicco, Alessandro; Raiteri, Riccardo; Rossati, Antonella; Savarino, Andrea; Di Perri, Giovanni Letter to the editor May 1, 2000 902
About the Drug Fact Sheets. Mar 1, 2000 363

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters